BJH - 2025, issue Special, april 2025
P. Meijer PhD
During the BHS annual meeting, Lieven Annemans (senior professor of health economics at the Faculty of Medicine, Ghent University) posed the rhetorical question: “Are cancer drugs too expensive?” He offered a nuanced perspective by reviewing the advantages and disadvantages of various pricing models, ongoing challenges, and future opportunities.
Read more
Top
